We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

148 hedge funds and large institutions have $426M invested in Esperion Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

444% more call options, than puts

Call options by funds: $22.5M | Put options by funds: $4.14M

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

21% more capital invested

Capital invested by funds: $352M → $426M (+$73.4M)

9% more funds holding

Funds holding: 136148 (+12)

7.35% more ownership

Funds ownership: 87.8%95.15% (+7.3%)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
148
Holders Change
+12
Holders Change %
+8.82%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
22
Increased
59
Reduced
41
Closed
9
Calls
$22.5M
Puts
$4.14M
Net Calls
+$18.4M
Net Calls Change
+$6.78M